Table 1 |
||||
|
Gene Ontology enrichment analysis for six out of seven effective genes whose overexpression perturbed the mES transcriptome in a statistically significant manner |
||||
|
Gene |
Gene Ontology term |
FDR |
Fold enrichment |
Reference |
|
|
||||
|
Runx1 |
Negative regulation of progression through cell cycle |
2.8 |
1.5 |
|
|
Positive regulation of cell proliferation |
0.5 |
1.5 |
||
|
Vasculature development |
0.1 |
1.5 |
||
|
Blood vessel development |
0.2 |
1.5 |
||
|
Blood vessel morphogenesis |
0.1 |
1.6 |
||
|
Angiogenesis |
0.1 |
1.6 |
||
|
Regulation of myeloid cell differentiation |
0.8 |
2.1 |
[63] |
|
|
Skeletal development |
0.2 |
1.5 |
[64] |
|
|
Skeletal morphogenesis |
1.7 |
2.5 |
[64] |
|
|
Regulation of cell differentiation |
0.0 |
1.7 |
[65] |
|
|
Erg |
Anatomical structure formation |
0.2 |
1.5 |
[66] |
|
Angiogenesis |
0.0 |
1.6 |
||
|
Regulation of cell differentiation |
0.8 |
1.5 |
||
|
Cell growth |
2.3 |
1.5 |
||
|
Regulation of cell migration |
1.3 |
1.8 |
||
|
Negative regulation of transcription, DNA-dependent |
0.5 |
1.5 |
[68] |
|
|
Nrip1 |
Muscle cell differentiation |
2.0 |
4.3 |
[69] |
|
Nervous system development |
0,1 |
2.0 |
[70] |
|
|
Negative regulation of transcription, DNA-dependent |
3.6 |
2.6 |
[71] |
|
|
Olig2 |
Organ morphogenesis |
0.5 |
1.6 |
|
|
Placenta development |
1.3 |
4.3 |
[74] |
|
|
Negative regulation of progression through cell cycle |
3.6 |
2.1 |
[75] |
|
|
Pdxk |
Cellular macromolecule catabolic process |
2.0 |
2.7 |
|
|
Cellular carbohydrate metabolic process |
0.0 |
4.1 |
||
|
Amino acid biosynthetic process |
0.6 |
7.3 |
[78] |
|
|
Aire |
Cell morphogenesis |
0.0 |
1.6 |
[79] |
|
Regulation of progression through cell cycle |
0.0 |
1.7 |
[79] |
|
|
Regulation of cell differentiation |
0.4 |
1.9 |
[79] |
|
|
Cell migration |
4.0 |
1.5 |
[80] |
|
|
|
||||
|
Perturbation of the mES transcriptome was as assessed by microarray analysis. GO analysis was performed on the list of differentially expressed genes using the DAVID tool, restricting the output to biological process terms of levels 4 and 5, with a significance threshold FDR < 5% and fold enrichment ≥ 1.5%. Supporting references confirming GO analysis are reported in the 'References' column. |
||||
|
De Cegli et al. Genome Biology 2010 11:R64 doi:10.1186/gb-2010-11-6-r64 |
||||